Preoperative Gut Microbiome Profiling Linking Microbial Signatures to Anastomotic Leakage Risk

  • Challenge assumptions around clinical endpoints and trial design to improve translational success
  • Address cost-of-goods and production scalability to unlock sustainable development pathways
  • Reframe the probiotic–drug divide to clarify modality, mechanism, and market potential